Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Biophytis stock
Learn how to easily invest in Biophytis stock.
Biophytis is a biotechnology business based in the US. Biophytis shares (BPTS) are listed on the NASDAQ and all prices are listed in US Dollars. Biophytis employs 24 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Biophytis stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BPTS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Biophytis stock price (NASDAQ: BPTS)Use our graph to track the performance of BPTS stocks over time.
Biophytis shares at a glance
|Latest market close||$0.43|
|52-week range||$0.35 - $3.36|
|50-day moving average||$0.48|
|200-day moving average||$0.68|
|Wall St. target price||$15.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.82|
Buy Biophytis stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Biophytis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Biophytis price performance over time
Historical closes compared with the close of $0.429 from 2023-03-24
|1 week (2023-03-21)||4.38%|
|1 month (2023-02-28)||3.13%|
|3 months (2022-12-28)||8.61%|
|6 months (2022-09-28)||-32.44%|
|1 year (2022-03-28)||-84.23%|
|2 years (2021-03-26)||-96.65%|
|3 years (2020-03-24)||N/A|
|5 years (2018-03-24)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-50.67%|
|Return on equity TTM||-680.78%|
|Market capitalisation||$10.4 million|
TTM: trailing 12 months
Biophytis share dividends
We're not expecting Biophytis to pay a dividend over the next 12 months.
You may also wish to consider:
- CVS Health (CVS.US) (3.23% forward annual dividend yield)
- UnitedHealth Group Incorporated (UNH.US) (1.38% forward annual dividend yield)
- McKesson Corporation (MCK.US) (0.63% forward annual dividend yield)
Have Biophytis's shares ever split?
Biophytis's shares were split on a 1:10 basis on 30 March 2023. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Biophytis shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Biophytis shares which in turn could have impacted Biophytis's share price.
Biophytis share price volatility
Over the last 12 months, Biophytis's shares have ranged in value from as little as $0.35 up to $3.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biophytis's is 1.1834. This would suggest that Biophytis's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Biophytis's beta into context you can compare it against those of similar companies.
- CVS Health (CVS.US): 0.6289
- UnitedHealth Group Incorporated (UNH.US): 0.6924
- McKesson Corporation (MCK.US): 0.5917
Biophytis S. A. , a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD.
Biophytis in the news
Biophytis: Biophytis Presented Sarconeos (BIO101) As A Possible Treatment Candidate for Long COVID After Hospitalization During The 13th Annual International Conference on Frailty and Sarcopenia Resea
Biophytis Announces Ratio Change Under its American Depositary Receipt (“ADR”) Program
Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference
Frequently asked questionsWhat percentage of Biophytis is owned by institutions?
Currently 0.44% of Biophytis shares are held by institutions. How many people work for Biophytis?
Latest data suggests 24 work at Biophytis. When does the fiscal year end for Biophytis?
Biophytis's fiscal year ends in December. Where is Biophytis based?
Biophytis's address is: Sorbonne University, Paris, France, 75005 What is Biophytis's ISIN number?
Biophytis's international securities identification number is: US09076G1040
More guides on Finder
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
How to Buy Gold Stocks
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert